Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Reader Login
Users Online :2690
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission


Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2017| December  | Volume 54 | Issue 5  
    Online since December 29, 2017

  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
A review on adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in nonsmall cell lung cancer patients
B Biswas, N Ghadyalpatil, MV Krishna, J Deshmukh
December 2017, 54(5):55-64
DOI:10.4103/ijc.IJC_589_17  PMID:29292709
  8 5,879 458
Epidermal growth factor receptor T790M testing in progressed lung cancer: A review of sensitive methods for analysis of tissue and liquid biopsy samples
A Chougule, S Basak
December 2017, 54(5):45-54
DOI:10.4103/ijc.IJC_540_17  PMID:29292708
  6 4,836 380
Importance of repeat tissue biopsy and tissue-based epidermal growth factor receptor T790M testing in progressed nonsmall cell lung carcinoma patients upon negative plasma genotyping for selection of third-generation tyrosine kinase inhibitor therapy: A case study
R Mistry, A Patil
December 2017, 54(5):65-66
DOI:10.4103/ijc.IJC_545_17  PMID:29292710
  4 3,192 260
Epidermal growth factor receptor T790M mutation: A major culprit in the progression of epidermal growth factor receptor-driven non-small cell lung cancer and the role of repeat biopsy
S Aggarwal, S Patil, N Rohtagi
December 2017, 54(5):15-24
DOI:10.4103/ijc.IJC_510_17  PMID:29292704
  4 4,529 310
Liquid biopsy: A potential and promising diagnostic tool for advanced stage non-small cell lung cancer patients
DC Doval, R Deshpande, B Dhabhar, KG Babu, K Prabhash, R Chopra, PV Sripada, C Deshmukh, M Suryavanshi
December 2017, 54(5):25-30
DOI:10.4103/ijc.IJC_514_17  PMID:29292705
  4 5,705 471
Role of epidermal growth factor receptor-tyrosine kinase inhibitors in the management of central nervous system metastases in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer patients
U Batra, N Lokeshwar, S Gupta, P Shirsath
December 2017, 54(5):37-44
DOI:10.4103/ijc.IJC_532_17  PMID:29292707
  4 4,433 373
Oncogenic drivers in nonsmall cell lung cancer and resistance to epidermal growth factor receptor tyrosine kinase inhibitors
A Pathak, S Rajappa, A Gore
December 2017, 54(5):1-8
DOI:10.4103/ijc.IJC_505_17  PMID:29292702
  3 5,604 1,533
Epidermal growth factor receptor mutation testing: From conventional to real-time diagnosis of lung cancer
T Raja, NK Warrier
December 2017, 54(5):9-14
DOI:10.4103/ijc.IJC_507_17  PMID:29292703
  2 6,214 531
Advanced therapeutic options and importance of rebiopsy in epidermal growth factor receptor-tyrosine kinase inhibitor-progressed nonsmall cell lung carcinoma patients: An expert opinion
Suresh H Advani, Hemant Malhotra, Raju Titus Chacko, Maheboob Basade, Pavithran Keechilat, PN Mahapatra, Chanchal Goswami, TP Sahoo, Chirag Shah
December 2017, 54(5):31-36
DOI:10.4103/ijc.IJC_520_17  PMID:29292706
  1 4,301 310
  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow